logo
Share SHARE
FONT-SIZE Plus   Neg

Barry Callebaut H1 Profit Declines; Backs Growth Forecast - Quick Facts

Barry Callebaut AG (BYCBF.PK), a Swiss manufacturer of cocoa and chocolate products, on Monday said its first-half net profit declined 18 percent to 121.8 million Swiss Francs from 148.6 million francs last year due to higher operating expenses as well as higher financing costs related to the bond placement in summer 2011. In local currencies, profit fell 11.3 percent.

Sales volume grew 6.7 percent to 699,058 tonnes and again outperformed the worldwide chocolate confectionery market, the company said. Sales revenue increased 3 percent to 2.48 billion francs from last year's 2.40 billion francs. Sales grew 10.4 percent in local currencies.

The company noted that all regions and product groups contributed to the volume growth, which rebounded strongly in the second quarter.

CEO Juergen Steinemann said, "After an anticipated slow start in Q1, we regained momentum in Q2, in all Regions and across all Product Groups. Once again, we outpaced the global chocolate market. Several major new partnership deals were signed, confirming an important part of our business model. In the last six months, we initiated selective investments in our future growth. This temporarily affected our bottom-line results."

Looking ahead, the company said it is confident of reaching mid-term financial targets, even though the economic environment in Western Europe and North America remains fragile.

The company's four-year growth targets for 2009/10-2012/13 include on average 6-8 percent volume growth and average EBIT growth in local currencies at least in line with volume growth.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year. As the din settles down on a dismal quarter at one of the world's exciting tech company, it is time to sit back and take stock of what went wrong and will the wrong be righted in the near term?
comments powered by Disqus
Follow RTT